Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Among patients with metabolic dysfunction associated steatohepatitis (MASH), is resmetirom 80 or 100mg superior to placebo in reversing MASH and/or fibrosis on liver biopsy, and is it safe?].
Lanthier L, Grbic D, Plourde MÉ, Cauchon M. Lanthier L, et al. Among authors: grbic d. Rev Med Interne. 2024 May 15:S0248-8663(24)00569-1. doi: 10.1016/j.revmed.2024.05.007. Online ahead of print. Rev Med Interne. 2024. PMID: 38755073 French. No abstract available.
Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study.
Plagiannakos CG, Hirschfield GM, Lytvyak E, Roberts SB, Ismail M, Gulamhusein AF, Selzner N, Qumosani KM, Worobetz L, Hercun J, Vincent C, Flemming JA, Swain MG, Cheung A, Chen T, Grbic D, Peltekain K, Mason AL, Montano-Loza AJ, Hansen BE; Canadian Network for Autoimmune Liver Disease (CaNAL). Plagiannakos CG, et al. Among authors: grbic d. J Hepatol. 2024 Mar 24:S0168-8278(24)00205-8. doi: 10.1016/j.jhep.2024.03.021. Online ahead of print. J Hepatol. 2024. PMID: 38527524 Free article.
Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trial.
Maranda B, Labbé SM, Lurquin M, Brabant P, Fugère A, Larrivée JF, Grbic D, Leroux A, Leduc F, Finzi A, Gaudreau S, Swart Y; IBIO-INH-001 Investigators. Maranda B, et al. Among authors: grbic d. Lancet Infect Dis. 2024 Jan;24(1):25-35. doi: 10.1016/S1473-3099(23)00393-6. Epub 2023 Aug 21. Lancet Infect Dis. 2024. PMID: 37619584 Clinical Trial.
CastNet: a systems-level sequence evolution simulator.
Rivera-Rivera CJ, Grbic D. Rivera-Rivera CJ, et al. Among authors: grbic d. BMC Bioinformatics. 2023 Jun 12;24(1):247. doi: 10.1186/s12859-023-05366-1. BMC Bioinformatics. 2023. PMID: 37308829 Free PMC article.
63 results